Wednesday, 21 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14691
Articles
Company
Drug
Fosun Pharma’s FS-1502 Gets NMPA Approval for Gastric Cancer Study
March 2, 2025
Company
Drug
GeneScience’s Somatropin Wins NMPA Approval for Prader-Willi Syndrome
March 2, 2025
Company
Drug
Inmagene and HutchMed Dose First Patient in IMG-007 Global Phase I Study
March 2, 2025
Company
Deals
ClinChoice Raises USD 150M in Funding Led by Legend Capital for Expansion
March 2, 2025
Drug
InnoCare Pharma’s BCL2 Inhibitor ICP-248 Accepted for NMPA Review
March 2, 2025
Company
Deals
Shenzhen TargetRx Raises Hundreds of Millions in Series B Financing for Drug Development
March 2, 2025
Drug
Ascletis Pharma Files IND Application for ASC10 with US FDA
March 2, 2025
Company
Drug
MabPharm’s CMAB017 Receives NMPA Approval for Clinical Study in Solid Tumors
March 2, 2025
Company
Deals
Zhejiang Medicine’s NovoCodex Subsidiary Receives RMB 402M Investment
March 2, 2025
Company
Deals
Medicilon Biomedical Plans RMB 2.16B Private Placement for R&D Expansion
March 2, 2025
Company
Drug
Hansoh Pharmaceutical’s Generic Ibrance Approved by NMPA
March 2, 2025
Company
Digital
Alibaba Health’s 2022 Financial Report Shows Revenue Growth, Net Loss
March 2, 2025
1
2
…
1,203
1,204
1,205
1,206
1,207
…
1,224
1,225
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?